J. McMannis

1.4k citations

41 papers · 1.0k indexed · h-index 15

Impact in

Hematology top 2%
- Hematopoietic Stem Cell Transplantation
Genetics top 2%
- Mesenchymal stem cell research

Papers in ⓘ

Hematology 20
- Hematopoietic Stem Cell Transplantation 17
- Acute Myeloid Leukemia Research 4
Transplantation 3

Co-authors: Marcos de Lima (14 shared papers)Safa Karandish (9 shared papers)Richard E. Champlin (13 shared papers)Elizabeth J. Shpall (13 shared papers)Stephen P. Creekmore (2 shared papers)T. Sadeghi (5 shared papers)Donald P. Braun (2 shared papers)Richard I. Fisher (2 shared papers)
Journals: Biology of Blood and Marrow Transplantation (8 papers)Journal of Clinical Oncology (6 papers)Bone Marrow Transplantation (6 papers)Cytotherapy (5 papers)Blood (3 papers)
Partner nations: United States Israel Canada

In The Last Decade

J. McMannis

41 papers receiving 1.0k citations

Peers

Countries citing papers authored by J. McMannis

Since Specialization

Citations

This map shows the geographic impact of J. McMannis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. McMannis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. McMannis more than expected).

Fields of papers citing papers by J. McMannis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. McMannis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. McMannis. The network helps show where J. McMannis may publish in the future.

Co-authors

The 25 scholars most cited alongside J. McMannis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. McMannis Line = papers co-authored together J. McMannis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells Bone Marrow Transplantation ·Simon N. Robinson, Jia Q. Ng, Ting Niu, Hui Yang, J. McMannis, Safa Karandish, Indreshpal Kaur, Pengbo Fu, M. Angel, R. Messinger, F. Flagge, Marcos de Lima, William K. Decker, Dajun Xing, R. Champlin, E.J. Shpall	2006	184
2	Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial Bone Marrow Transplantation ·Marcos de Lima, J. McMannis, Adrian P. Gee, Krishna V. Komanduri, Daniel Couriel, Börje S. Andersson, Chitra Hosing, Issa F. Khouri, Roy B. Jones, Richard E. Champlin, Safa Karandish, T. Sadeghi, T. Peled, Frida Grynspan, Yaron Daniely, Arnon Nagler, Elizabeth J. Shpall	2008	183
3	In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2. The Journal of Immunology ·J. McMannis, Richard I. Fisher, Stephen P. Creekmore, Donald P. Braun, James Harris, Thomas M. Ellis	1988	71
4	Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans. PubMed ·David H. Boldt, Bonnie Mills, Brett T. Gemlo, Howard T. Holden, J W Mier, Elisabeth Paietta, J. McMannis, Laura V. Escobedo, Irena Sniecinski, Anthony A. Rayner	1988	67
5	Ex vivo expansion of umbilical cord blood Cytotherapy ·Sydney K. Robinson, Ting Niu, Marcos de Lima, Jia Q. Ng, Hui Yang, J. McMannis, Safa Karandish, T. Sadeghi, Pengbo Fu, M. Angel, Seán O’Connor, Richard E. Champlin, Elizabeth J. Shpall	2005	56
6	Frequent detection of tumor cells in hematopoietic grafts in neuroblastoma and Ewing’s sarcoma Bone Marrow Transplantation ·Wing Leung, Allen Chen, RC Klann, TJ Moss, John M. Davis, SJ Noga, K. H. Cohen, AD Friedman, Donald Small, C. L. Schwartz, MJ Borowitz, MD Wharam, Charles N. Paidas, CA Long, Safa Karandish, J. McMannis, MB Kastan, CI Civin	1998	54
7	Effects of interleukin 2 on cardiac function in the isolated rat heart. Journal of Clinical Investigation ·P A Sobotka, J. McMannis, R I Fisher, D G Stein, J. X. Thomas	1990	44
8	Appearance and phenotypic characterization of circulating Leu 19+ cells in cancer patients receiving recombinant interleukin 2. PubMed ·Tom Ellis, Stephen P. Creekmore, J. McMannis, Donald P. Braun, J A Harris, Richard I. Fisher	1988	43
9	Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT Bone Marrow Transplantation ·Stefan O. Ciurea, Rima M. Saliba, Gabriela Rondón, Susana Pesoa, Pedro Cano, Marcelo Fernández-Viña, S. Qureshi, Laura L. Worth, J. McMannis, Partow Kebriaei, Roy B. Jones, M Körbling, Muzaffar H. Qazilbash, Elizabeth J. Shpall, Sergio Giralt, Marcos de Lima, Richard E. Champlin, James Gajewski	2009	42
10	Microbial contamination of hematopoietic progenitor cell products: clinical outcome Bone Marrow Transplantation ·Poliana Patah, S. Parmar, J. McMannis, T. Sadeghi, Safa Karandish, Gabriela Rondón, Jeffery Tarrand, Richard E. Champlin, Marcos de Lima, Elizabeth J. Shpall	2007	37
11	A phase I study of immune gene therapy for patients with CLL using a membrane-stable, humanized CD154 Leukemia ·William G. Wierda, Januario E. Castro, Robier A. Aguillon, Deepa Sampath, Annette Jalayer, J. McMannis, Charles Prussak, Michael J. Keating, Thomas J. Kipps	2010	36
12	Mobilized CD34+ cells selected as autografts in patients with primary light‐chain amyloidosis: rationale and application Transfusion ·R Comenzo, D Michelle, M. M. LeBlanc, Jeremy Wally, Yue Zhang, Geraldina Kica, Safa Karandish, CF Arkin, DG Wright, M Skinner, J. McMannis	1998	35
13	Double loading of dendritic cell MHC class I and MHC class II with an AML antigen repertoire enhances correlates of T-cell immunity in vitro via amplification of T-cell help Vaccine ·Walter J. Decker, Deyin Xing, S LI, Stephen Robinson, Hong Yang, Xin Yao, H.J. Segall, J. McMannis, Krishna V. Komanduri, R CHAMPLIN	2006	30
14	Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity Cytotherapy ·Simrit Parmar, Simon N. Robinson, Krishna V. Komanduri, Lisa S. St. John, William K. Decker, Dajun Xing, Hong Yang, J. McMannis, Richard E. Champlin, Marcos de Lima, Jeffery Molldrem, Alyssa G. Rieber, Mark Bonyhadi, Ronald Berenson, Elizabeth J. Shpall	2006	29
15	High Risk of Graft Failure in Patients With Anti-HLA Antibodies Undergoing Haploidentical Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Stefan O. Ciurea, Marcos de Lima, Pedro Cano, M Körbling, J. McMannis, Sergio Giralt, Elizabeth J. Shpall, Richard E. Champlin, Marcelo Fernández-Viña	2009	24
16	Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancer Cytotherapy ·Robert A. Preti, H M Lazarus, Jane N. Winter, Edward A. Stadtmauer, Suzi Nadasi, J. McMannis, Safa Karandish, Andrew Jennis, Stuart L. Goldberg, Andrew L. Pecora	2001	11
17	Long-term follow up of patients who experienced graft failure post allogeneic progenitor cell transplantation Biology of Blood and Marrow Transplantation ·Gabriela Rondón, Issa F. Khouri, Sergio Giralt, K. W. Chan, J. McMannis, Richard E. Champlin, Elizabeth J. Shpall	2005	9
18	Donor lymphocyte apheresis for adoptive immunotherapy compared with blood stem cell apheresis Journal of Clinical Apheresis ·M Körbling, Sergio Giralt, Issa F. Khouri, Nadeem Q. Mirza, Michèle L. Donato, Paolo Anderlini, Harald E. Fischer, Michael Andreeff, J. McMannis, Richard E. Champlin	2001	8
19	AML-loaded DC generate Th1-type cellular immune responses in vitro Cytotherapy ·Dajun Xing, William K. Decker, S. Li, Simon N. Robinson, Hong Yang, H L Segal, Seán O’Connor, Xin Yao, Krishna V. Komanduri, J. McMannis, Roy B. Jones, Marcos de Lima, Richard E. Champlin, E.J. Shpall	2006	7
20	A novel triple purge strategy for eliminating chronic myelogenous leukemia (CML) cells from autografts Bone Marrow Transplantation ·Hong Yang, Connie J. Eaves, M. Lima, M.-S. Lee, R. Champlin, J. McMannis, Simon N. Robinson, Ting Niu, William K. Decker, Dajun Xing, Jia Q. Ng, S. Li, Xin Yao, Allen Eaves, Roy Jones, Börje S. Andersson, E.J. Shpall	2006	6

About J. McMannis

J. McMannis is a scholar working on Hematology, Transplantation, Genetics, Immunology and Oncology, having authored 41 papers that have together received 1.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (17 papers), Immunotherapy and Immune Responses (10 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers), Mesenchymal stem cell research (5 papers), CAR-T cell therapy research (5 papers), Acute Myeloid Leukemia Research (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Hematology (535 citations), Genetics (360 citations), Immunology (376 citations), Oncology (300 citations) and Transplantation (24 citations). J. McMannis has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Marcos de Lima, Safa Karandish, Richard E. Champlin, Elizabeth J. Shpall, Stephen P. Creekmore, T. Sadeghi, Donald P. Braun, Richard I. Fisher, Krishna V. Komanduri and Hui Yang. Their work appears in journals such as Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation, Cytotherapy and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact